Adenia Partners invests in leading pharmaceutical distributor in Madagascar

03 May 2016

Adenia Partners, a private equity fund manager focused on growth opportunities and mid-cap buyouts in Sub-Saharan Africa, has backed Opham, the leading pharmaceutical products wholesaler in Madagascar. Opham distributes more than 4,500 specialty and generic products to pharmacies and hospitals in the country. 

Adenia Partners co-invested with the Dutch development institution FMO and a family office, both being investors in Adenia Capital (III), a EUR96mn vehicle closed in 2012. Adenia and its co-investors intend to continue the expansion of the company and to improve access to affordable, high-quality pharmaceutical products for consumers across the country.


For more information, please see here.

« Back to Member News

RT @CDCgroup: #SDG5: Gender equality ♀️ What does it mean to ‘invest in women’? As evidence supporting the business case for women’s econo…

Helios Investment Partners achieves B-Corp status. Read more:

@AfricInvest_Grp exits its investment in leading generics manufacturing company, Polymedic. Read more:

@FMO_development makes first investment in DRC's financial sector. Read more:

Verod Capital Management closes Fund III at US$200mn. Read more: